OTC Hearing Aid and MCI
NCT06112860
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: improve communication Whether the magnitude of benefit depends on the patient's level of cognitive disability, Whether alternative remediation (such as targeted communication strategies) offer similar benefits.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hearing Loss
- Mild Cognitive Impairment
- Alzheimer Disease and Related Dementias (ADRD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 60 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Northwestern University
- Last updated on ClinicalTrials.gov
- September 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Northwestern University HA Lab · Evanston, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.